ADVANZ PHARMA GENERICS (UK) LIMITED

02760679
Active London

Manufacture of pharmaceutical preparations

0 employees website.com
Manufacture of pharmaceutical preparations
A

ADVANZ PHARMA GENERICS (UK) LIMITED

02760679

Manufacture of pharmaceutical preparations

Founded 30 Oct 1992 Active London, United Kingdom 0 employees website.com
Manufacture of pharmaceutical preparations

Previous Company Names

MERCURY PHARMA (GENERICS) LIMITED 20 Mar 2012 — 30 Oct 2018
FORLEY GENERICS LIMITED 26 Aug 1999 — 20 Mar 2012
GOLDSHIELD FORLEY LIMITED 13 Aug 1999 — 26 Aug 1999
GOLDSHIELD GENERICS LIMITED 13 May 1997 — 13 Aug 1999
GAMAACE LIMITED 30 Oct 1992 — 13 May 1997
Accounts Submitted 30 Jun 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 21 Jul 2025 Next due 21 Jul 2026 1 month remaining
Net assets £12M £1M 2024 year on year
Total assets £23M £3M 2024 year on year
Total Liabilities £11M £4M 2024 year on year
Charges 11
1 outstanding 10 satisfied

Contact & Details

Contact

Registered Address

Dashwood House 69 Old Broad Street London EC2M 1QS United Kingdom

Full company profile for ADVANZ PHARMA GENERICS (UK) LIMITED (02760679), an active company based in London, United Kingdom. Incorporated 30 Oct 1992. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£1.29M

Decreased by £2.42M (-65%)

Net Assets

£11.81M

Increased by £1.43M (+14%)

Total Liabilities

£10.81M

Decreased by £3.95M (-27%)

Turnover

£45.06M

Decreased by £1.53M (-3%)

Employees

N/A

Debt Ratio

48%

Decreased by 11 (-19%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Mercury Pharma Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 1 Jun 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Mercury Pharma Group Limited

Ceased 27 Mar 2020

Ceased

The Blackstone Group Inc.

Ceased 1 Jun 2021

Ceased

Group Structure

Group Structure

ADVANZ PHARMA GENERICS (UK) LIMITED Current Company

Charges

Charges

1 outstanding 10 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Jul 2025Confirmation StatementConfirmation statement made on 7 Jul 2025 with no updates
30 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
20 Feb 2025OfficersAppointment of Mr. Melvin Jeremy Ferry as director on 6 Feb 2025
19 Feb 2025OfficersTermination of Vikram Laxman Kamath as director on 6 Feb 2025
2 Sept 2024AccountsAnnual accounts made up to 31 Dec 2023
21 Jul 2025 Confirmation Statement

Confirmation statement made on 7 Jul 2025 with no updates

30 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

20 Feb 2025 Officers

Appointment of Mr. Melvin Jeremy Ferry as director on 6 Feb 2025

19 Feb 2025 Officers

Termination of Vikram Laxman Kamath as director on 6 Feb 2025

2 Sept 2024 Accounts

Annual accounts made up to 31 Dec 2023

Recent Activity

Latest Activity

Confirmation statement made on 7 Jul 2025 with no updates

11 months ago on 21 Jul 2025

Annual accounts made up to 31 Dec 2024

11 months ago on 30 Jun 2025

Appointment of Mr. Melvin Jeremy Ferry as director on 6 Feb 2025

1 years ago on 20 Feb 2025

Termination of Vikram Laxman Kamath as director on 6 Feb 2025

1 years ago on 19 Feb 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 2 Sept 2024